EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H16Cl2F2N4O2 |
| Net Charge | 0 |
| Average Mass | 429.254 |
| Monoisotopic Mass | 428.06184 |
| SMILES | Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl |
| InChI | InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1 |
| InChIKey | AXTAPYRUEKNRBA-JTQLQIEISA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. central nervous system stimulant Any drug that enhances the activity of the central nervous system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| uprosertib (CHEBI:755163) has role antineoplastic agent (CHEBI:35610) |
| uprosertib (CHEBI:755163) is a amphetamines (CHEBI:35338) |
| INN | Source |
|---|---|
| uprosertib | WHO MedNet |
| Synonyms | Source |
|---|---|
| Akt inhibitor gsk-2141795 | ChEMBL |
| Akt inhibitor gsk2141795 | ChEMBL |
| Gsk-2141795 | ChEMBL |
| GSK2141795 | ChEMBL |
| GSK-2141795C | ChEMBL |
| GSK2141795C | ChEMBL |
| Citations |
|---|